BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 3607115)

  • 1. Dexamethasone suppression test and urinary MHPG X SO4 determination in depressive disorders.
    Zhou DF; Shen YC; Shu LN; Lo HC
    Biol Psychiatry; 1987 Jul; 22(7):883-91. PubMed ID: 3607115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of correlation between DST results and urinary MHPG in depressed inpatients.
    Lôo H; Poirier MF; Dennis T; Benkelfat C; Vanelle JM; Gay C; Galinowski A; Askienazy S; Scatton B
    J Neural Transm; 1988; 72(2):121-30. PubMed ID: 3385423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cortisol secretion and urinary MHPG in unipolar depression.
    Sternbach HA; Extein I; Sweeney DR; Gold MS; Pottash AL
    Int J Psychiatry Med; 1983-1984; 13(4):261-6. PubMed ID: 6671859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dexamethasone suppression test in patients with mood disorders.
    Rush AJ; Giles DE; Schlesser MA; Orsulak PJ; Parker CR; Weissenburger JE; Crowley GT; Khatami M; Vasavada N
    J Clin Psychiatry; 1996 Oct; 57(10):470-84. PubMed ID: 8909334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melatonin, cortisol and ACTH in patients with major depressive disorder and healthy humans with special reference to the outcome of the dexamethasone suppression test.
    Beck-Friis J; Ljunggren JG; Thorén M; von Rosen D; Kjellman BF; Wetterberg L
    Psychoneuroendocrinology; 1985; 10(2):173-86. PubMed ID: 2994141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [DST urinary MHPG.SO4 excretion and platelet MAO activity in depression].
    Zhou DF
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Oct; 18(5):274-8. PubMed ID: 3833511
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasma MHPG in depressive disorders and relationship to the dexamethasone suppression test.
    Roy A; Jimerson DC; Pickar D
    Am J Psychiatry; 1986 Jul; 143(7):846-51. PubMed ID: 3717423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated 3,4-dihydroxyphenylethyleneglycol (DHPG) excretion in dexamethasone resistant depressed patients.
    Warsh JJ; Hasey G; Cooke RG; Stancer HC; Persad E; Jorna T; Godse DD
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(5-6):661-4. PubMed ID: 4089190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The relation between results of thyrotropin-releasing hormone stimulation tests (TRH-ST), dexamethasone suppression test (DST) and urinary MHPG. SO4 excretion in depressive patients].
    Chen G
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Aug; 24(4):203-6, 251. PubMed ID: 1954790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward a biochemical classification of depressive disorders. I. Differences in urinary excretion of MHPG and other catecholamine metabolites in clinically defined subtypes of depressions.
    Schildkraut JJ; Orsulak PJ; Schatzberg AF; Gudeman JE; Cole JO; Rohde WA; LaBrie RA
    Arch Gen Psychiatry; 1978 Dec; 35(12):1427-33. PubMed ID: 727878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limited clinical utility of urinary MHPG.
    Lieber AL
    Hillside J Clin Psychiatry; 1988; 10(1):98-104. PubMed ID: 3137145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noradrenergic function and the dexamethasone suppression test in depression.
    Morinobu S; Satoh H; Endoh M; Totsuka S
    Jpn J Psychiatry Neurol; 1987 Dec; 41(4):669-76. PubMed ID: 3453415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depressive symptom patterns and urinary MHPG excretion.
    Agren H
    Psychiatry Res; 1982 Apr; 6(2):185-96. PubMed ID: 6953458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association of MHPG to dexamethasone suppression test status.
    Garvey MJ; Hollon S; Evans M; DeRubeis RJ; Tuason VB
    Psychiatry Res; 1988 May; 24(2):223-30. PubMed ID: 3406240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible clinical applications of laboratory tests in depression.
    Fiori M; Davis KL
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):6-11. PubMed ID: 6370977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cortisol response to dexamethasone and noradrenergic function in depression.
    Maes M; de Ruyter M; Suy E
    Acta Psychiatr Scand; 1987 Feb; 75(2):171-5. PubMed ID: 3565061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroendocrine and neurochemical measurements in depression.
    Davis KL; Hollister LE; Mathé AA; Davis BM; Rothpearl AB; Faull KF; Hsieh JY; Barchas JD; Berger PA
    Am J Psychiatry; 1981 Dec; 138(12):1555-62. PubMed ID: 6171169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catecholamines in depression: a cumulative study of urinary norepinephrine and its major metabolites in unipolar and bipolar depressed patients versus healthy volunteers at the NIMH.
    Grossman F; Potter WZ
    Psychiatry Res; 1999 Jul; 87(1):21-7. PubMed ID: 10512151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of noradrenaline metabolism in depressed patients by the determination of plasma dihydroxyphenylethylene glycol].
    Lôo H; Scatton B; Dennis T; Benkelfat C; Gay C; Poirier-Littré MF; Garreau M; Vanelle JM; Olié JP; Deniker P
    Encephale; 1983; 9(4):297-316. PubMed ID: 6671452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexamethasone suppression test response in major depression: stability across hospitalizations.
    Coryell W; Schlesser MA
    Psychiatry Res; 1983 Mar; 8(3):179-89. PubMed ID: 6574537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.